🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 5

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 5 of 9
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Aug 5, 2025 at 1:50 AM#21
Dr.PathRoch said:
If you are going to change something, change one thing and give it long enough to express itself.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

40 13NauseaFreeNow, SteveThurs, B12Beth and 37 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Aug 14, 2025 at 3:37 PM#22
Dr.PathRoch said:
If you are going to change something, change one thing and give it long enough to express itself.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

41 14JessicaH_TX, KevinCompounds, TirzTom and 38 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Aug 24, 2025 at 5:29 AM#23

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

42 15wanda_boise, NurseAsh_DET, BenResearch_OR and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Sep 2, 2025 at 7:27 PM#24
traveltech_sara said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

43 16LondonLisa, mike_nyc, VendorMark and 40 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Sep 12, 2025 at 9:30 AM#25
traveltech_sara said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Coming at traveltech_sara’s question from a different direction. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Sep 12, 2025 at 10:30 AM
44 17TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 41 others
Reply Quote Save Share Report
1345679

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register